Peoples Financial Services CORP. trimmed its position in Oracle Corporation (NYSE:ORCL - Free Report) by 43.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,628 shares of the enterprise software provider's stock after selling 5,188 shares during the quarter. Peoples Financial Services CORP.'s holdings in Oracle were worth $910,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in the company. North Point Portfolio Managers Corp OH bought a new position in shares of Oracle during the third quarter valued at about $27,000. Maseco LLP purchased a new stake in shares of Oracle during the first quarter worth about $29,000. Persistent Asset Partners Ltd bought a new stake in shares of Oracle in the second quarter worth about $29,000. Markowski Investments bought a new stake in shares of Oracle in the second quarter worth about $32,000. Finally, MBM Wealth Consultants LLC purchased a new position in Oracle during the 1st quarter valued at about $33,000. 42.44% of the stock is owned by hedge funds and other institutional investors.
Oracle Stock Up 2.0%
Oracle stock traded up $2.56 during trading hours on Tuesday, hitting $132.15. 12,853,342 shares of the stock traded hands, compared to its average volume of 29,392,359. The firm's 50-day moving average price is $144.95 and its two-hundred day moving average price is $158.66. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 1.89. The company has a market cap of $399.59 billion, a PE ratio of 20.73, a PEG ratio of 0.90 and a beta of 1.78. Oracle Corporation has a one year low of $114.50 and a one year high of $287.19.
Oracle (NYSE:ORCL - Get Free Report) last announced its earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.18. The firm had revenue of $19.34 billion during the quarter, compared to analyst estimates of $19.13 billion. Oracle had a return on equity of 48.85% and a net margin of 26.36%. The business's revenue was up 29.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.47 EPS. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. On average, research analysts forecast that Oracle Corporation will post 6.73 EPS for the current year.
Oracle Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 23rd. Shareholders of record on Friday, October 9th will be issued a $0.50 dividend. The ex-dividend date is Friday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.5%. Oracle's dividend payout ratio is 31.35%.
Trending Headlines about Oracle
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Potential Nvidia financing support: TD Cowen said Nvidia may help finance Oracle’s new AI data centers, potentially reducing the amount Oracle must fund directly and easing concerns about its capital requirements. Nvidia May Be Helping Finance Oracle’s AI Data Centers
- Positive Sentiment: Analyst sees substantial upside: Bank of America reiterated a bullish outlook and set a valuation implying significant appreciation potential, reinforcing the view that Oracle’s recent selloff may have created a compelling entry point. Bank of America Resets Oracle Price Target
- Positive Sentiment: Improving demand indicators: A BNP Paribas reseller survey reportedly showed a major improvement in Oracle-related demand, while multicloud database revenue grew sharply in the latest quarter. Selling database services through rival clouds could expand Oracle’s addressable market without requiring customers to migrate applications. Oracle Sees Stronger AI Demand
- Positive Sentiment: Healthcare AI expansion: Oracle and AstraZeneca will explore AI and real-world data tools for clinical-trial recruitment and healthcare workflows, broadening Oracle’s growth story beyond data centers. Oracle and AstraZeneca Partner
- Neutral Sentiment: Execution remains central: Oracle said construction at its Project Jupiter data-center campus is moving quickly, but investors are still assessing whether the buildout can generate sufficient returns.
- Negative Sentiment: Debt and funding risks persist: Reports warn Oracle’s bonds could face downgrade pressure as AI financing concerns spread. The company’s large backlog— reportedly heavily concentrated in OpenAI—also raises customer-concentration and execution risks. Oracle Bonds Face Downgrade Risks
Insiders Place Their Bets
In related news, CEO Michael D. Sicilia sold 22,562 shares of Oracle stock in a transaction dated Tuesday, September 22nd. The shares were sold at an average price of $151.59, for a total transaction of $3,420,173.58. Following the completion of the transaction, the chief executive officer directly owned 182,929 shares of the company's stock, valued at $27,730,207.11. This trade represents a 10.98% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Maria Smith sold 2,631 shares of the business's stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of $151.70, for a total transaction of $399,122.70. Following the sale, the executive vice president directly owned 64,357 shares in the company, valued at $9,762,956.90. The trade was a 3.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 36,075 shares of company stock worth $5,342,123. 38.40% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on the company. Royal Bank Of Canada lowered their price target on Oracle from $190.00 to $165.00 and set a "sector perform" rating for the company in a research report on Friday, September 11th. Scotiabank cut their price objective on Oracle from $241.00 to $215.00 and set a "sector outperform" rating on the stock in a research report on Wednesday, September 9th. President Capital reduced their target price on Oracle from $360.00 to $300.00 and set an "overweight" rating on the stock in a research note on Tuesday, July 14th. DA Davidson restated a "buy" rating and set a $225.00 target price on shares of Oracle in a report on Friday, September 11th. Finally, BMO Capital Markets decreased their target price on Oracle from $220.00 to $195.00 and set an "outperform" rating for the company in a report on Friday, September 11th. One analyst has rated the stock with a Strong Buy rating, thirty-five have given a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $249.52.
Read Our Latest Analysis on Oracle
About Oracle
(
Free Report)
Oracle Corporation NYSE: ORCL is a global technology company that develops enterprise software, cloud infrastructure and database technologies. Its products help organizations store, manage, analyze and secure data, while supporting business operations across industries and geographies.
The company's offerings include Oracle Database, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud-based applications. These applications serve functions such as enterprise resource planning, financial management, human resources, supply-chain management, customer experience and industry-specific operations.
See Also
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.